Loading market data...
Latest Top News
Show more
Eris Lifesciences Delivers Strong Q4: Revenue Soars to ₹7.05 Billion, Net Profit at ₹938 Million
Eris Lifesciences Ltd has reported robust financial results for the March 2025 quarter, underscoring its momentum in the branded formulations and specialty pharma space. The company’s consolidated revenue from operations surged to ₹7.05 billion, while net profit reached ₹938.4 million, refl...
Stay Ahead – Explore Now! Union Bank Of India Launches Debut Infrastructure Bond






